Abstract
Gynecologic cancers are an important cause of worldwide mortality. The interstitium consists of solid and fluid phases, situated between the blood vessels and cells. The interstitial fluid (IF), or fluid phase, is an extracellular fluid bathing and surrounding the tissue cells. The TIF (tumor interstitial fluid) is a dynamic fluid rich in lipids, proteins and enzyme-derived substances. The molecules found in the IF may be associated with pathological changes in tissues leading to cancer growth and metastatization. Proteomic techniques have allowed an extensive study of the composition of the TIF as a source of biomarkers for gynecologic cancers. In our review, we analyze the composition of the TIF, its formation process, the sampling methods, the consequences of its accumulation and the proteomic analyses performed, that make TIF valuable for monitoring different types of cancers.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference111 articles.
1. WHO: GLOBOCAN 2012 Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012http://globocan.iarc.fr
2. Targeting tumor microenvironment: Crossing tumor interstitial fluid by multifunctional nanomedicines;Omidi;Bioimpacts,2014
3. Screening for ovarian cancer: Imaging challenges and opportunities for improvement;Mathieu;Ultrasound. Obstet. Gynecol.,2017
4. Interstitial fluid flow in cancer: implications for disease progression and treatment
5. Fibroblasts in cancer
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献